Topical noninvasive retinal drug delivery of a tyrosine kinase inhibitor: 3% cediranib maleate cyclodextrin nanoparticle eye drops in the rabbit eye

Solubility and stability of cediranib maleate

(2021) Pitsiree Praphanwittaya et al.   JOURNAL OF DRUG DELIVERY SCIENCE AND TECHNOLOGY

Micelle-solubilized axitinib for ocular administration in anti-neovascularization

(2019) Shuai Shi et al.   INTERNATIONAL JOURNAL OF PHARMACEUTICS

Aqueous solubility of kinase inhibitors: I the effect of hydrophilic polymers on their γ-cyclodextrin solubilization

(2019) Pitsiree Praphanwittaya et al.   JOURNAL OF DRUG DELIVERY SCIENCE AND TECHNOLOGY

Topical drug delivery to the posterior segment of the eye: Dexamethasone concentrations in various eye tissues after topical administration for up to 15 days to rabbits

(2018) Sunna Johannsdottir et al.   JOURNAL OF DRUG DELIVERY SCIENCE AND TECHNOLOGY

Cyclodextrins and topical drug delivery to the anterior and posterior segments of the eye

(2017) Thorsteinn Loftsson et al.   INTERNATIONAL JOURNAL OF PHARMACEUTICS

Physicochemical Characterization and Cyclodextrin Complexation of the Anticancer Drug Lapatinib

(2017) Gergő Tóth et al.   Journal of Chemistry

Clinical Pharmacokinetics and Pharmacodynamics of Cabozantinib

(2016) Steven A. Lacy et al.   CLINICAL PHARMACOKINETICS

Applications of cyclodextrins in medical textiles — review

(2016) Cezar-Doru Radu et al.   JOURNAL OF CONTROLLED RELEASE

DLS and zeta potential – What they are and what they are not?

(2016) Sourav Bhattacharjee   JOURNAL OF CONTROLLED RELEASE

Self-Assembly of Cyclodextrins and Their Complexes in Aqueous Solutions

(2016) Alexey Ryzhakov et al.   JOURNAL OF PHARMACEUTICAL SCIENCES

Targeting VEGF in eye neovascularization: What's new?

(2016) Marialaura Amadio et al.   PHARMACOLOGICAL RESEARCH

Topical dexamethasone-cyclodextrin nanoparticle eye drops for non-infectious Uveitic macular oedema and vitritis - a pilot study

(2015) Shiri Shulman et al.   ACTA OPHTHALMOLOGICA

Topical dexamethasoneγ-cyclodextrin nanoparticle eye drops increase visual acuity and decrease macular thickness in diabetic macular oedema

(2015) Akihiro Ohira et al.   ACTA OPHTHALMOLOGICA

A New Approach for Quantitative Determination of γ-Cyclodextrin in Aqueous Solutions: Application in Aggregate Determinations and Solubility in Hydrocortisone/γ-Cyclodextrin Inclusion Complex

(2015) Phennapha Saokham et al.   JOURNAL OF PHARMACEUTICAL SCIENCES

Physicochemical characterisation and cyclodextrin complexation of erlotinib

(2015) Gergő Tóth et al.   SUPRAMOLECULAR CHEMISTRY

Kinetics ofγ-cyclodextrin nanoparticle suspension eye drops in tear fluid

(2013) Gauti Jóhannesson et al.   ACTA OPHTHALMOLOGICA

Adverse events and complications associated with intravitreal injection of anti-VEGF agents: a review of literature

(2013) K Ghasemi Falavarjani et al.   EYE

A Study on Solubilization of Poorly Soluble Drugs by Cyclodextrins and Micelles: Complexation and Binding Characteristics of Sulfamethoxazole and Trimethoprim

(2012) Sinem Göktürk et al.   TheScientificWorldJOURNAL

Cyclodextrin solubilization of carbonic anhydrase inhibitor drugs: Formulation of dorzolamide eye drop microparticle suspension

(2010) Phatsawee Jansook et al.   EUROPEAN JOURNAL OF PHARMACEUTICS AND BIOPHARMACEUTICS

Diabetic retinopathy

(2010) Ning Cheung et al.   LANCET

Gefitinib–cyclodextrin inclusion complexes: physico-chemical characterization and dissolution studies

(2009) Y.-H. Phillip Lee et al.   DRUG DEVELOPMENT AND INDUSTRIAL PHARMACY

Cediranib: profile of a novel anti-angiogenic agent in patients with glioblastoma

(2009) Jörg Dietrich et al.   EXPERT OPINION ON INVESTIGATIONAL DRUGS

Age-related macular degeneration: diagnosis and management

(2008) H. L. Cook et al.   BRITISH MEDICAL BULLETIN